"Smolej, L." . "chronic lymphocytic leukemia; cytogenetics; IgVh mutation status; prognostic markers; survival"@en . . . "Trn\u011Bn\u00FD, Marek" . . "RIV/00023736:_____/11:00009273!RIV12-MZ0-00023736" . . . "2"^^ . "I, P(NS10439), P(NS9858), P(NT11217), P(NT11218), V, Z(MSM0021620808), Z(MZ0FNHK2005)" . "Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice" . "The impact of modern prognostic markers on clinical course of chronic lymphocytic leukemia (CLL) in everyday practice has been not yet well-defined, especially in large series of patients. Therefore, the goal of the present study was to assess the influence of conventional as well as modern prognostic factors on overall survival (OS) and time to therapy (TTT) of CLL patients. Methods: We retrospectively analyzed data of all patients consecutively entered into the databases of five large academic centers in the Czech Republic. The total of 1300 patients was included in the analysis. Results and conclusion: Through the use of uniparametric analysis, it was determined that gender, clinical stage Rai II-IV, unmutated IgVH status, 17p deletion (for both 5% and 20% cut-off), 11q deletion, ZAP-70 positivity and high expression of CD38 had significant negative influence on OS. TTT was significantly influenced by gender, Rai stage, IgVH status, 11q deletion, 17p deletion, 13q deletion and by CD" . "RIV/00023736:_____/11:00009273" . . . . "8"^^ . "Posp\u00ED\u0161ilov\u00E1, \u0160." . "[0CEA894AA591]" . "Obrtl\u00EDkov\u00E1, P." . "10.1111/j.1600-0609.2011.01639.x" . . . "Brychtov\u00E1, Y." . . "http://dx.doi.org/10.1111/j.1600-0609.2011.01639.x" . "DK - D\u00E1nsk\u00E9 kr\u00E1lovstv\u00ED" . "Kozmon, P." . "Doubek, M." . . . "Mayer, J." . . . "Schwarz, Ji\u0159\u00ED" . . "000292778800005" . . "Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice"@en . "213256" . "The impact of modern prognostic markers on clinical course of chronic lymphocytic leukemia (CLL) in everyday practice has been not yet well-defined, especially in large series of patients. Therefore, the goal of the present study was to assess the influence of conventional as well as modern prognostic factors on overall survival (OS) and time to therapy (TTT) of CLL patients. Methods: We retrospectively analyzed data of all patients consecutively entered into the databases of five large academic centers in the Czech Republic. The total of 1300 patients was included in the analysis. Results and conclusion: Through the use of uniparametric analysis, it was determined that gender, clinical stage Rai II-IV, unmutated IgVH status, 17p deletion (for both 5% and 20% cut-off), 11q deletion, ZAP-70 positivity and high expression of CD38 had significant negative influence on OS. TTT was significantly influenced by gender, Rai stage, IgVH status, 11q deletion, 17p deletion, 13q deletion and by CD"@en . . . . "0902-4441" . "European Journal of Haematology" . . . "12"^^ . . . "Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice"@en . . "Cmunt, E." . . "Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice" . "Brejcha, M." . "87" . "2" . "Posp\u00ED\u0161il, Z." . .